Provided by Tiger Fintech (Singapore) Pte. Ltd.

ATAI Life Sciences B.V.*

2.41
-0.0700-2.82%
Post-market: 2.430.0200+0.83%19:51 EDT
Volume:4.65M
Turnover:11.47M
Market Cap:483.81M
PE:-2.59
High:2.55
Open:2.55
Low:2.37
Close:2.48
Loading ...
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Oct 04, 2024

Major Issues Report

Form 8-K - Current report
Sep 27, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities